Targeting	O
MYC	B:C0086661
as	O
a	O
therapeutic	O
intervention	I:C0808232
for	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
.	O

Targeting	O
MYC	O
as	O
a	O
therapeutic	B:C0808232
intervention	I:C0808232
for	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
.	O

Targeting	O
MYC	O
as	O
a	O
therapeutic	O
intervention	I:C0808232
for	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
.	O

Recent	B:C2603343
studies	I:C2603343
showed	O
that	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
is	O
driven	O
by	O
interaction	O
of	O
bromodomain	O
and	I:C0033684
extraterminal	I:C0033684
domain	I:C0033684
(	I:C0033684
BET	I:C0033684
)	I:C0033684
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
on	O
chromatin	O
.	O

Recent	O
studies	I:C2603343
showed	O
that	O
transcription	B:C0040649
of	O
the	O
MYC	O
gene	I:C0086661
is	O
driven	O
by	O
interaction	O
of	O
bromodomain	O
and	I:C0033684
extraterminal	I:C0033684
domain	I:C0033684
(	I:C0033684
BET	I:C0033684
)	I:C0033684
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
on	O
chromatin	O
.	O

Recent	O
studies	I:C2603343
showed	O
that	O
transcription	O
of	O
the	O
MYC	B:C0086661
gene	I:C0086661
is	O
driven	O
by	O
interaction	O
of	O
bromodomain	O
and	I:C0033684
extraterminal	I:C0033684
domain	I:C0033684
(	I:C0033684
BET	I:C0033684
)	I:C0033684
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
on	O
chromatin	O
.	O

Recent	O
studies	I:C2603343
showed	O
that	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
is	O
driven	O
by	O
interaction	O
of	O
bromodomain	B:C0033684
and	I:C0033684
extraterminal	I:C0033684
domain	I:C0033684
(	I:C0033684
BET	I:C0033684
)	I:C0033684
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
on	O
chromatin	O
.	O

Recent	O
studies	I:C2603343
showed	O
that	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
is	O
driven	O
by	O
interaction	O
of	O
bromodomain	O
and	I:C0033684
extraterminal	I:C0033684
domain	I:C0033684
(	I:C0033684
BET	I:C0033684
)	I:C0033684
proteins	I:C0033684
with	O
acetylated	B:C2753333
histones	I:C2753333
on	O
chromatin	O
.	O

Recent	O
studies	I:C2603343
showed	O
that	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
is	O
driven	O
by	O
interaction	O
of	O
bromodomain	O
and	I:C0033684
extraterminal	I:C0033684
domain	I:C0033684
(	I:C0033684
BET	I:C0033684
)	I:C0033684
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
on	O
chromatin	B:C0008546
.	O

A	O
potent	B:C1254351
inhibitor	I:C1254351
,	O
JQ1	O
,	O
which	O
effectively	O
disrupts	O
the	O
interaction	O
of	O
BET	O
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
,	O
preferentially	O
suppresses	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
.	O

A	O
potent	O
inhibitor	I:C1254351
,	O
JQ1	B:C3252362
,	O
which	O
effectively	O
disrupts	O
the	O
interaction	O
of	O
BET	O
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
,	O
preferentially	O
suppresses	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
.	O

A	O
potent	O
inhibitor	I:C1254351
,	O
JQ1	O
,	O
which	O
effectively	O
disrupts	O
the	O
interaction	O
of	O
BET	B:C0033684
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
,	O
preferentially	O
suppresses	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
.	O

A	O
potent	O
inhibitor	I:C1254351
,	O
JQ1	O
,	O
which	O
effectively	O
disrupts	O
the	O
interaction	O
of	O
BET	O
proteins	I:C0033684
with	O
acetylated	B:C2753333
histones	I:C2753333
,	O
preferentially	O
suppresses	O
transcription	O
of	O
the	O
MYC	O
gene	I:C0086661
.	O

A	O
potent	O
inhibitor	I:C1254351
,	O
JQ1	O
,	O
which	O
effectively	O
disrupts	O
the	O
interaction	O
of	O
BET	O
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
,	O
preferentially	O
suppresses	O
transcription	B:C0040649
of	O
the	O
MYC	O
gene	I:C0086661
.	O

A	O
potent	O
inhibitor	I:C1254351
,	O
JQ1	O
,	O
which	O
effectively	O
disrupts	O
the	O
interaction	O
of	O
BET	O
proteins	I:C0033684
with	O
acetylated	O
histones	I:C2753333
,	O
preferentially	O
suppresses	O
transcription	O
of	O
the	O
MYC	B:C0086661
gene	I:C0086661
.	O

We	O
recently	B:C0700287
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	B:C3252362
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	B:C0040136
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	B:C0184511
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	B:C2986594
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	B:C0086661
transcription	O
.	O

We	O
recently	O
reported	I:C0700287
that	O
JQ1	O
decreased	O
thyroid	O
tumor	I:C0040136
growth	O
and	O
improved	O
survival	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
(	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
)	O
by	O
targeting	O
MYC	O
transcription	B:C0040649
.	O

It	O
remains	O
to	O
be	O
elucidated	O
on	O
the	O
role	O
of	O
MYC	B:C1454487
in	I:C1454487
human	I:C1454487
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
and	O
whether	O
JQ1	O
could	O
effectively	O
target	O
MYC	O
as	O
a	O
novel	O
treatment	I:C0009429
modality	I:C0009429
.	O

It	O
remains	O
to	O
be	O
elucidated	O
on	O
the	O
role	O
of	O
MYC	O
in	I:C1454487
human	I:C1454487
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
and	O
whether	O
JQ1	O
could	O
effectively	O
target	O
MYC	O
as	O
a	O
novel	O
treatment	I:C0009429
modality	I:C0009429
.	O

It	O
remains	O
to	O
be	O
elucidated	O
on	O
the	O
role	O
of	O
MYC	O
in	I:C1454487
human	I:C1454487
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
and	O
whether	O
JQ1	O
could	O
effectively	O
target	O
MYC	B:C1454487
as	O
a	O
novel	O
treatment	I:C0009429
modality	I:C0009429
.	O

It	O
remains	O
to	O
be	O
elucidated	O
on	O
the	O
role	O
of	O
MYC	O
in	I:C1454487
human	I:C1454487
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
and	O
whether	O
JQ1	O
could	O
effectively	O
target	O
MYC	O
as	O
a	O
novel	B:C0009429
treatment	I:C0009429
modality	I:C0009429
.	O

To	O
understand	O
underlying	O
molecular	B:C3537153
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	B:C0086418
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	B:C0220825
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	B:C0086418
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	B:C0085983
lines	I:C0085983
and	O
xenograft	O
models	I:C1520166
.	O

To	O
understand	O
underlying	O
molecular	O
mechanisms	I:C3537153
of	O
JQ1's	O
effects	O
on	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
JQ1	O
in	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
and	O
xenograft	B:C1520166
models	I:C1520166
.	O

We	O
determined	O
the	O
effects	O
of	O
JQ1	O
on	O
proliferation	O
and	O
invasion	B:C1269955
in	O
cell	O
lines	I:C0085983
and	O
xenograft	O
tumors	O
.	O

We	O
determined	O
the	O
effects	O
of	O
JQ1	O
on	O
proliferation	O
and	O
invasion	O
in	O
cell	B:C0085983
lines	I:C0085983
and	O
xenograft	O
tumors	O
.	O

We	O
determined	O
the	O
effects	O
of	O
JQ1	O
on	O
proliferation	O
and	O
invasion	O
in	O
cell	O
lines	I:C0085983
and	O
xenograft	B:C0520484
tumors	O
.	O

We	O
determined	O
the	O
effects	O
of	O
JQ1	O
on	O
proliferation	O
and	O
invasion	O
in	O
cell	O
lines	I:C0085983
and	O
xenograft	O
tumors	B:C0027651
.	O

We	O
identified	O
key	O
regulators	O
critical	O
for	O
JQ1	O
-	O
affected	O
proliferation	O
and	O
invasion	B:C1269955
of	I:C1269955
tumor	I:C1269955
cells	I:C1269955
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	O
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	O
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	B:C0085983
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	O
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	O
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	B:C1454487
and	O
elevation	O
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	O
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	B:C0702240
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	O
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	O
of	O
p21	B:C0598086
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	O
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	O
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	B:C1158886
Rb	O
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	O
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	B:C0080113
to	O
delay	O
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
markedly	O
inhibited	O
proliferation	O
of	O
4	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
cell	O
lines	I:C0085983
by	O
suppression	O
of	O
MYC	O
and	O
elevation	O
of	O
p21	O
and	I:C0598086
p27	I:C0598086
to	O
decrease	O
phosphorylated	O
Rb	O
to	O
delay	B:C0007586
cell	I:C0007586
cycle	I:C0007586
progression	O
from	O
the	O
G0	O
/	O
G1	O
phase	O
to	O
the	O
S	O
phase	O
.	O

JQ1	O
blocked	O
cell	B:C1269955
invasion	I:C1269955
by	O
attenuating	O
epithelial	O
mesenchymal	I:C1523298
transition	I:C1523298
signals	I:C1523298
.	O

JQ1	O
blocked	O
cell	O
invasion	I:C1269955
by	O
attenuating	O
epithelial	B:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
signals	I:C1523298
.	O

These	O
cell	B:C2603343
-	I:C2603343
based	I:C2603343
studies	I:C2603343
were	O
further	O
confirmed	O
in	O
xenograft	O
studies	O
in	O
that	O
the	O
size	O
and	O
rate	O
of	O
tumor	O
growth	O
was	O
inhibited	O
by	O
JQ1	O
via	O
inhibition	O
of	O
p21	O
-	I:C0037080
Cyclin	I:C0037080
/	I:C0037080
CDK	I:C0037080
-	I:C0037080
Rb	I:C0037080
-E2	I:C0037080
F	I:C0037080
signaling	I:C0037080
.	O

These	O
cell	O
-	I:C2603343
based	I:C2603343
studies	I:C2603343
were	O
further	O
confirmed	B:C0750484
in	O
xenograft	O
studies	O
in	O
that	O
the	O
size	O
and	O
rate	O
of	O
tumor	O
growth	O
was	O
inhibited	O
by	O
JQ1	O
via	O
inhibition	O
of	O
p21	O
-	I:C0037080
Cyclin	I:C0037080
/	I:C0037080
CDK	I:C0037080
-	I:C0037080
Rb	I:C0037080
-E2	I:C0037080
F	I:C0037080
signaling	I:C0037080
.	O

These	O
cell	O
-	I:C2603343
based	I:C2603343
studies	I:C2603343
were	O
further	O
confirmed	O
in	O
xenograft	B:C0520484
studies	O
in	O
that	O
the	O
size	O
and	O
rate	O
of	O
tumor	O
growth	O
was	O
inhibited	O
by	O
JQ1	O
via	O
inhibition	O
of	O
p21	O
-	I:C0037080
Cyclin	I:C0037080
/	I:C0037080
CDK	I:C0037080
-	I:C0037080
Rb	I:C0037080
-E2	I:C0037080
F	I:C0037080
signaling	I:C0037080
.	O

These	O
cell	O
-	I:C2603343
based	I:C2603343
studies	I:C2603343
were	O
further	O
confirmed	O
in	O
xenograft	O
studies	B:C2603343
in	O
that	O
the	O
size	O
and	O
rate	O
of	O
tumor	O
growth	O
was	O
inhibited	O
by	O
JQ1	O
via	O
inhibition	O
of	O
p21	O
-	I:C0037080
Cyclin	I:C0037080
/	I:C0037080
CDK	I:C0037080
-	I:C0037080
Rb	I:C0037080
-E2	I:C0037080
F	I:C0037080
signaling	I:C0037080
.	O

These	O
cell	O
-	I:C2603343
based	I:C2603343
studies	I:C2603343
were	O
further	O
confirmed	O
in	O
xenograft	O
studies	O
in	O
that	O
the	O
size	B:C0456389
and	O
rate	O
of	O
tumor	O
growth	O
was	O
inhibited	O
by	O
JQ1	O
via	O
inhibition	O
of	O
p21	O
-	I:C0037080
Cyclin	I:C0037080
/	I:C0037080
CDK	I:C0037080
-	I:C0037080
Rb	I:C0037080
-E2	I:C0037080
F	I:C0037080
signaling	I:C0037080
.	O

These	O
cell	O
-	I:C2603343
based	I:C2603343
studies	I:C2603343
were	O
further	O
confirmed	O
in	O
xenograft	O
studies	O
in	O
that	O
the	O
size	O
and	O
rate	O
of	O
tumor	O
growth	O
was	O
inhibited	O
by	O
JQ1	O
via	O
inhibition	O
of	O
p21	B:C0037080
-	I:C0037080
Cyclin	I:C0037080
/	I:C0037080
CDK	I:C0037080
-	I:C0037080
Rb	I:C0037080
-E2	I:C0037080
F	I:C0037080
signaling	I:C0037080
.	O

These	O
results	O
suggest	O
targeting	O
MYC	B:C1454487
protein	I:C1454487
could	O
be	O
a	O
potential	O
novel	O
treatment	I:C0009429
modality	I:C0009429
for	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
for	O
which	O
effective	O
treatment	O
options	I:C0683525
are	O
limited	O
.	O

These	O
results	O
suggest	O
targeting	O
MYC	O
protein	I:C1454487
could	O
be	O
a	O
potential	O
novel	B:C0009429
treatment	I:C0009429
modality	I:C0009429
for	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
for	O
which	O
effective	O
treatment	O
options	I:C0683525
are	O
limited	O
.	O

These	O
results	O
suggest	O
targeting	O
MYC	O
protein	I:C1454487
could	O
be	O
a	O
potential	O
novel	O
treatment	I:C0009429
modality	I:C0009429
for	O
human	B:C0086418
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
for	O
which	O
effective	O
treatment	O
options	I:C0683525
are	O
limited	O
.	O

These	O
results	O
suggest	O
targeting	O
MYC	O
protein	I:C1454487
could	O
be	O
a	O
potential	O
novel	O
treatment	I:C0009429
modality	I:C0009429
for	O
human	O
anaplastic	B:C0238461
thyroid	I:C0238461
cancer	I:C0238461
for	O
which	O
effective	O
treatment	O
options	I:C0683525
are	O
limited	O
.	O

These	O
results	O
suggest	O
targeting	O
MYC	O
protein	I:C1454487
could	O
be	O
a	O
potential	O
novel	O
treatment	I:C0009429
modality	I:C0009429
for	O
human	O
anaplastic	O
thyroid	I:C0238461
cancer	I:C0238461
for	O
which	O
effective	O
treatment	B:C0683525
options	I:C0683525
are	O
limited	O
.	O

